VANGUARD GROUP INC - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is and the CUSIP is 162828206. A total of 39 filers reported holding CHECKPOINT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$820,482
-14.4%
482,637
+24.4%
0.00%
Q2 2023$958,162
+28.3%
387,920
+16.9%
0.00%
Q1 2023$746,926
-51.6%
331,967
+9.9%
0.00%
Q4 2022$1,542,899301,9370.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 111,025$188,7421.29%
SABBY MANAGEMENT, LLC 205,247$348,9200.26%
ARMISTICE CAPITAL, LLC 2,064,000$3,508,8000.05%
Legacy Wealth Asset Management, LLC 85,000$144,5000.05%
EMFO, LLC 15,715$26,7160.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 12,801$21,7620.01%
XTX Topco Ltd 20,941$35,6000.01%
Ethos Financial Group, LLC 12,060$20,5020.01%
B. Riley Wealth Advisors, Inc. 49,150$83,5550.00%
PARK AVENUE SECURITIES LLC 59,932$1020.00%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders